Patent · US Active

Non-invasive test to predict recurrence of colorectal cancer

US11821041B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

Roche Sequencing Solutions, Inc. · US

Inventors

Hans Adams · Cologne, DE
Aarthi Balasubramanyam · Sunnyvale, US
Bernd Hinzmann · Berlin, DE
John J. Lee · New York, US
John F. Palma · Alamo, US
Andre Rosenthal · Jena, DE
Urich-Peter Rohr · Lörrach, DE

Key dates

Filing date	Aug 7, 2019
Grant date	Nov 21, 2023
Priority date	—
Expiry date	Oct 22, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention is a method of predicting recurrence of colorectal cancer in a patient following surgery, the method comprising analysis of circulating tumor DNA from a patient's sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.